| 1 | Adenitis | 28.6% |
| 2 | Follicular cyst | 28.6% |
| 3 | Histiocytosis | 28.6% |
| 4 | Lymphadenitis | 28.6% |
| 5 | Lymphangitis | 28.6% |
| 6 | Lymphedema | 28.6% |
| 7 | Mucocele | 28.6% |
| 8 | Pilonidal Cyst | 28.6% |
| 9 | Splenic Diseases | 28.6% |
| 10 | Thymus Hyperplasia | 28.6% |
| 11 | Thyroglossal Cyst | 28.6% |
| 12 | Synovial Cyst | 28.6% |
| 13 | Pseudolymphoma | 28.6% |
| 14 | Lymphadenopathy | 28.6% |
| 15 | Thymus Neoplasms | 26.3% |
| 16 | Dermoid Cyst | 25.2% |
| 17 | Lymphangiectasis, Intestinal | 24.7% |
| 18 | Histiocytic Disorders, Malignant | 22.8% |
| 19 | Splenic Neoplasms | 22.8% |
| 20 | Lymphoproliferative Disorders | 21.4% |
| 21 | Pancreatic Cyst | 21.4% |
| 22 | Lymphatic Abnormalities | 21.4% |
| 23 | Breast Cyst | 21.1% |
| 24 | Mediastinal Cyst | 21.1% |
| 25 | Parovarian Cyst | 21.1% |
| 26 | Pericardial Cyst | 21.1% |
| 27 | Thymic Cyst | 21.1% |
| 28 | Myxoid cyst | 21.1% |
| 29 | Elephantiasis | 20.9% |
| 30 | Hypersplenism | 20.9% |
| 31 | Sarcoidosis | 20.9% |
| 32 | Elephantiasis Nostras Verrucosa | 20.9% |
| 33 | Thymoma | 19.7% |
| 34 | Lymphoma | 18.1% |
| 35 | Malignant histiocytosis | 17.9% |
| 36 | Histiocytic sarcoma | 17.9% |
| 37 | Lymphohistiocytosis, Hemophagocytic | 17.2% |
| 38 | Erdheim-Chester Disease | 17.2% |
| 39 | Agammaglobulinemia | 16.7% |
| 40 | Mucocutaneous Lymph Node Syndrome | 16.7% |
| 41 | Corpus Luteum Cyst | 16.5% |
| 42 | Ovarian Cysts | 16.5% |
| 43 | Sezary Syndrome | 16.4% |
| 44 | Granuloma | 15.8% |
| 45 | Splenic Infarction | 15.8% |
| 46 | Heavy Chain Disease | 15.6% |
| 47 | Histiocytosis, Langerhans-Cell | 15.5% |
| 48 | Pancreatic Pseudocyst | 15.5% |
| 49 | Tumor Lysis Syndrome | 15.5% |
| 50 | Composite Lymphoma | 15.2% |
| 51 | Hamartoma | 15% |
| 52 | Neoplasms, Hormone-Dependent | 15% |
| 53 | Neoplasms, Multiple Primary | 15% |
| 54 | Paraneoplastic Syndromes | 15% |
| 55 | Precancerous Conditions | 15% |
| 56 | Neoplasms, Second Primary | 15% |
| 57 | Waldenstrom Macroglobulinemia | 14.3% |
| 58 | Hematologic Neoplasms | 14.3% |
| 59 | Hodgkin Disease | 14.2% |
| 60 | Lymphoma, Non-Hodgkin | 14.2% |
| 61 | Lymphomatoid Granulomatosis | 14.1% |
| 62 | Choledochal Cyst | 14% |
| 63 | Lymphangioleiomyomatosis | 13.9% |
| 64 | Infectious Mononucleosis | 13.6% |
| 65 | Leukemia, T-Cell | 13.4% |
| 66 | Leukemia, B-Cell | 13.4% |
| 67 | Sarcoidosis, Pulmonary | 12.8% |
| 68 | Splenic Rupture | 12.7% |
| 69 | Lymphoma, Follicular | 12.3% |
| 70 | T-Cell Lymphoma | 12.3% |
| 71 | Mantle cell lymphoma | 12.3% |
| 72 | Disseminated Intravascular Coagulation | 12.3% |
| 73 | Protein S Deficiency | 12.3% |
| 74 | Bone Marrow Neoplasms | 12.3% |
| 75 | Polycystic Ovary Syndrome | 12.1% |
| 76 | Thrombocythemia, Essential | 12% |
| 77 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 12% |
| 78 | Leukemia, Large Granular Lymphocytic | 12% |
| 79 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 12% |
| 80 | Carcinoma 256, Walker | 11.9% |
| 81 | Lymphoma, T-Cell, Cutaneous | 11.4% |
| 82 | Lymphoma, AIDS-Related | 11.4% |
| 83 | Enteropathy-Associated T-Cell Lymphoma | 11.4% |
| 84 | Primary Effusion Lymphoma | 11.4% |
| 85 | Carcinoma, Ehrlich Tumor | 11.3% |
| 86 | Carcinoma, Lewis Lung | 11.3% |
| 87 | Neoplastic Processes | 11.1% |
| 88 | Neoplastic Syndromes, Hereditary | 11.1% |
| 89 | Polycythemia Vera | 11.1% |
| 90 | Pregnancy Complications, Neoplastic | 11.1% |
| 91 | Multiple Endocrine Neoplasia | 11% |
| 92 | Mycosis Fungoides | 11% |
| 93 | Lymphomatoid Papulosis | 11% |
| 94 | Plasmablastic lymphoma | 11% |
| 95 | Neoplasms, Experimental | 10.9% |
| 96 | Neoplasms, Neuroepithelial | 10.8% |
| 97 | Gliomatosis cerebri | 10.8% |
| 98 | Medulloblastoma | 10.6% |
| 99 | Autoimmune Lymphoproliferative Syndrome | 10.5% |
| 100 | Neuroectodermal Tumors | 10.3% |
| 101 | Melanoma, Experimental | 10.3% |
| 102 | Splenosis | 10.2% |
| 103 | melanoma | 10.1% |
| 104 | Paraneoplastic Encephalomyelitis | 9.9% |
| 105 | Trophoblastic Neoplasms | 9.7% |
| 106 | Eosinophilic Granuloma | 9.7% |
| 107 | Leukemia, Experimental | 9.7% |
| 108 | Mammary Neoplasms, Experimental | 9.7% |
| 109 | Thrombasthenia | 9.6% |
| 110 | Antithrombin III Deficiency | 9.6% |
| 111 | Protein C Deficiency | 9.6% |
| 112 | Abdominal Neoplasms | 9.5% |
| 113 | Anemia | 9.5% |
| 114 | Blood Coagulation Disorders | 9.5% |
| 115 | Blood Platelet Disorders | 9.5% |
| 116 | Bone Marrow Diseases | 9.5% |
| 117 | Erythroplasia | 9.5% |
| 118 | Head and Neck Neoplasms | 9.5% |
| 119 | Hemorrhagic Disorders | 9.5% |
| 120 | leukemia | 9.5% |
| 121 | Leukocyte Disorders | 9.5% |
| 122 | Methemoglobinemia | 9.5% |
| 123 | Neoplasms, Germ Cell and Embryonal | 9.5% |
| 124 | Neoplasms, Glandular and Epithelial | 9.5% |
| 125 | Pancytopenia | 9.5% |
| 126 | Polycythemia | 9.5% |
| 127 | Soft Tissue Neoplasms | 9.5% |
| 128 | Sulfhemoglobinemia | 9.5% |
| 129 | Thoracic Neoplasms | 9.5% |
| 130 | Thrombophilia | 9.5% |
| 131 | Germ Cell Cancer | 9.5% |
| 132 | Erythrocytosis | 9.5% |
| 133 | Aberrant Crypt Foci | 9.5% |
| 134 | Carcinosarcoma | 9.4% |
| 135 | Hemangiosarcoma | 9.4% |
| 136 | Leukemia L1210 | 9.4% |
| 137 | Leukemia P388 | 9.4% |
| 138 | lymphangiosarcoma | 9.4% |
| 139 | Thrombocytosis | 9.4% |
| 140 | Acanthoma | 9.4% |
| 141 | Adenoma, Acidophil | 9.3% |
| 142 | Ganglioneuroma | 9.3% |
| 143 | Glioma | 9.3% |
| 144 | Malignant Glioma | 9.3% |
| 145 | Meningioma | 9.2% |
| 146 | Basal Cell Nevus Syndrome | 9.2% |
| 147 | Afibrinogenemia | 9% |
| 148 | Factor VII Deficiency | 9% |
| 149 | Factor X Deficiency | 9% |
| 150 | Factor XII Deficiency | 9% |
| 151 | Hemophilia A | 9% |
| 152 | Activated Protein C Resistance | 9% |
| 153 | Factor II deficiency | 9% |
| 154 | Factor VIII Deficiency | 9% |
| 155 | Factor V deficiency | 9% |
| 156 | Factor XI Deficiency | 9% |
| 157 | Hypoprothrombinemias | 9% |
| 158 | Carcinoid Tumor | 9% |
| 159 | Neurilemmoma | 9% |
| 160 | Hutchinson's Melanotic Freckle | 9% |
| 161 | Melanoma, Amelanotic | 9% |
| 162 | Sarcoma 180 | 8.9% |
| 163 | Sarcoma, Experimental | 8.9% |
| 164 | Choriocarcinoma | 8.6% |
| 165 | Carcinoma, Lobular | 8.6% |
| 166 | Neoplasms, Radiation-Induced | 8.6% |
| 167 | Astrocytoma | 8.6% |
| 168 | Ependymoma | 8.6% |
| 169 | oligodendroglioma | 8.6% |
| 170 | Ganglioglioma | 8.6% |
| 171 | gliosarcoma | 8.6% |
| 172 | Anaplastic astrocytoma | 8.6% |
| 173 | Anaplastic Oligodendroglioma | 8.6% |
| 174 | Basal cell carcinoma | 8.5% |
| 175 | Carcinoma, Papillary | 8.5% |
| 176 | Squamous cell carcinoma | 8.5% |
| 177 | Chondrosarcoma | 8.5% |
| 178 | Craniopharyngioma | 8.5% |
| 179 | Cystadenoma | 8.5% |
| 180 | Hemoglobinuria, Paroxysmal | 8.5% |
| 181 | leiomyosarcoma | 8.5% |
| 182 | Leukemia, Myelomonocytic, Chronic | 8.5% |
| 183 | Leukemoid Reaction | 8.5% |
| 184 | liposarcoma | 8.5% |
| 185 | Mesothelioma | 8.5% |
| 186 | synovial sarcoma | 8.5% |
| 187 | Neuroectodermal Tumor, Melanotic | 8.5% |
| 188 | Angiomyolipoma | 8.5% |
| 189 | Clear Cell Sarcoma of Soft Tissue | 8.5% |
| 190 | Alveolar Soft Part Sarcoma | 8.5% |
| 191 | Neuroendocrine Tumors | 8.5% |
| 192 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 8.5% |
| 193 | Sarcoma, Myeloid | 8.5% |
| 194 | Carcinoma, Basal Cell | 8.5% |
| 195 | Malignant Carcinoid Syndrome | 8.4% |
| 196 | Glioblastoma | 8.3% |
| 197 | Neuroblastoma | 8.3% |
| 198 | Glioblastoma Multiforme | 8.3% |
| 199 | Multiple Endocrine Neoplasia Type 1 | 8.2% |
| 200 | Burkitt Lymphoma | 8.1% |
| 201 | Vitamin K Deficiency | 8.1% |
| 202 | Leukemia, Radiation-Induced | 8.1% |
| 203 | Ganglioneuroblastoma | 8.1% |
| 204 | Cystadenocarcinoma | 8% |
| 205 | Fibrosarcoma | 8% |
| 206 | Osteosarcoma | 8% |
| 207 | Mucoepidermoid Carcinoma | 8% |
| 208 | Adenofibroma | 7.8% |
| 209 | Fibroadenoma | 7.8% |
| 210 | Malignant Fibrous Histiocytoma | 7.8% |
| 211 | Anemia, Diamond-Blackfan | 7.8% |
| 212 | Bowen's Disease | 7.6% |
| 213 | Leukemia, Myeloid, Chronic-Phase | 7.6% |
| 214 | Paraganglioma | 7.6% |
| 215 | Rhabdomyosarcoma | 7.6% |
| 216 | Giant Cell Tumor of Bone | 7.6% |
| 217 | Tuberous Sclerosis | 7.5% |
| 218 | Leukemia, Plasma Cell | 7.4% |
| 219 | Digestive System Neoplasms | 7.4% |
| 220 | Endocrine Gland Neoplasms | 7.4% |
| 221 | Eye Neoplasms | 7.4% |
| 222 | Nervous System Neoplasms | 7.4% |
| 223 | Transfusion Reaction | 7.4% |
| 224 | Hypotensive Transfusion Reaction | 7.4% |
| 225 | Dermatofibrosarcoma | 7.3% |
| 226 | Dermatofibrosarcoma Protuberans | 7.3% |
| 227 | Bone neoplasms | 7.1% |
| 228 | Leukoplakia | 7.1% |
| 229 | Pregnancy Complications, Hematologic | 7.1% |
| 230 | Skin Neoplasms | 7.1% |
| 231 | Pheochromocytoma | 7.1% |
| 232 | Alveolar rhabdomyosarcoma | 7.1% |
| 233 | Retinoblastoma | 7.1% |
| 234 | Barrett Esophagus | 7% |
| 235 | Actinic keratosis | 7% |
| 236 | Neoplasm Invasiveness | 7% |
| 237 | Neoplasm Metastasis | 7% |
| 238 | Neoplasm Recurrence, Local | 7% |
| 239 | Carcinogenesis | 7% |
| 240 | Metastasis | 7% |
| 241 | Adenoma | 7% |
| 242 | Ameloblastoma | 7% |
| 243 | Anemia, Hemolytic | 7% |
| 244 | Anemia, Macrocytic | 7% |
| 245 | Angiokeratoma | 7% |
| 246 | Carcinoma | 7% |
| 247 | Chordoma | 7% |
| 248 | Eosinophilia | 7% |
| 249 | Hemangioma | 7% |
| 250 | hemangiopericytoma | 7% |
| 251 | Hypoproteinemia | 7% |
| 252 | Leukopenia | 7% |
| 253 | Lymphangioma | 7% |
| 254 | Mesenchymoma | 7% |
| 255 | Nevus | 7% |
| 256 | Parathyroid Neoplasms | 7% |
| 257 | Peritoneal Neoplasms | 7% |
| 258 | Retroperitoneal Neoplasms | 7% |
| 259 | Teratoma | 7% |
| 260 | Thrombocytopenia | 7% |
| 261 | Thyroid Neoplasm | 7% |
| 262 | Hepatoblastoma | 7% |
| 263 | Mixed Tumor, Mullerian | 7% |
| 264 | Germinoma | 7% |
| 265 | Teratocarcinoma | 7% |
| 266 | Angiofibroma | 7% |
| 267 | Leukostasis | 7% |
| 268 | Thyroid carcinoma | 7% |
| 269 | Sarcoma | 7% |
| 270 | Epithelioma | 7% |
| 271 | MYELODYSPLASTIC SYNDROME | 7% |
| 272 | Purpura, Thrombotic Thrombocytopenic | 6.9% |
| 273 | Carcinoma, Pancreatic Ductal | 6.9% |
| 274 | Carcinoid Heart Disease | 6.9% |
| 275 | Hemangioma, Cavernous | 6.8% |
| 276 | Multiple Myeloma | 6.7% |
| 277 | Acoustic Neuroma | 6.7% |
| 278 | Wiskott-Aldrich Syndrome | 6.5% |
| 279 | Tracheal Neoplasms | 6.4% |
| 280 | Vipoma | 6.4% |
| 281 | Hydatidiform Mole | 6.3% |
| 282 | Liver Neoplasms, Experimental | 6.3% |
| 283 | Leukoplakia, Oral | 6.2% |
| 284 | Neurofibrosarcoma | 6.2% |
| 285 | Paraneoplastic Cerebellar Degeneration | 6.2% |
| 286 | Nephroblastoma | 6.2% |
| 287 | Radicular Cyst | 6% |
| 288 | Pancreatic Neoplasm | 6% |
| 289 | Anemia, Sickle Cell | 5.9% |
| 290 | Thalassemia | 5.9% |
| 291 | Optic Nerve Glioma | 5.9% |
| 292 | Endometrial Stromal Sarcoma | 5.8% |
| 293 | Adenocarcinoma | 5.7% |
| 294 | Primary Myelofibrosis | 5.7% |
| 295 | Agranulocytosis | 5.7% |
| 296 | Anemia, Megaloblastic | 5.7% |
| 297 | Carcinoma in Situ | 5.7% |
| 298 | Carcinoma, Transitional Cell | 5.7% |
| 299 | Phyllodes Tumor | 5.7% |
| 300 | Dysgerminoma | 5.7% |
| 301 | Hemangioendothelioma | 5.7% |
| 302 | Lipoma | 5.7% |
| 303 | Lymphocytosis | 5.7% |
| 304 | Myelofibrosis | 5.7% |
| 305 | Myeloid Metaplasia | 5.7% |
| 306 | Myoma | 5.7% |
| 307 | Myxoma | 5.7% |
| 308 | Neuroma | 5.7% |
| 309 | Papilloma | 5.7% |
| 310 | Pseudomyxoma Peritonei | 5.7% |
| 311 | Seminoma | 5.7% |
| 312 | Papillomatosis | 5.7% |
| 313 | Angiolipoma | 5.7% |
| 314 | Myelolipoma | 5.7% |
| 315 | Neoplasms, Bone Tissue | 5.7% |
| 316 | Neoplasms, Fibrous Tissue | 5.7% |
| 317 | Smooth Muscle Tumor | 5.7% |
| 318 | Adenomatosis, Pulmonary | 5.7% |
| 319 | Adenomatous Polyps | 5.7% |
| 320 | Carcinoma, Large Cell | 5.7% |
| 321 | Hypoalbuminemia | 5.7% |
| 322 | Carcinoma, Small Cell | 5.7% |
| 323 | Desmoplastic Small Round Cell Tumor | 5.7% |
| 324 | Chondroma | 5.7% |
| 325 | Hypereosinophilic syndrome | 5.7% |
| 326 | Enchondroma | 5.7% |
| 327 | bone marrow fibrosis | 5.7% |
| 328 | Thrombotic Microangiopathies | 5.7% |
| 329 | Cryoglobulinemia | 5.6% |
| 330 | Monoclonal Gammopathy of Undetermined Significance | 5.6% |
| 331 | Thyroid Nodule | 5.6% |
| 332 | Hepatocellular Adenoma | 5.6% |
| 333 | insulinoma | 5.5% |
| 334 | Autoimmune thrombocytopenia | 5.5% |
| 335 | Immune thrombocytopenic purpura | 5.5% |
| 336 | Gastrinoma | 5.4% |
| 337 | Glucagonoma | 5.4% |
| 338 | Esophageal Neoplasms | 5.3% |
| 339 | Anemia, Neonatal | 5.3% |
| 340 | Leukocytosis | 5.3% |
| 341 | Mouth Neoplasms | 5.3% |
| 342 | Paraproteinemias | 5.3% |
| 343 | Pelger-Huet Anomaly | 5.3% |
| 344 | Central Nervous System Neoplasms | 5.3% |
| 345 | Pleocytosis | 5.3% |
| 346 | Vascular Neoplasms | 5.3% |
| 347 | Limbic Encephalitis | 5.3% |
| 348 | Hemolytic-Uremic Syndrome | 5.2% |
| 349 | Genital Neoplasms, Female | 5.2% |
| 350 | Plasmacytoma | 5.2% |
| 351 | Adenoid Cystic Carcinoma | 5.1% |
| 352 | fibroma | 5.1% |
| 353 | Fibromatosis | 5.1% |
| 354 | Neutropenia | 5.1% |
| 355 | Osteoblastoma | 5.1% |
| 356 | Osteoma | 5.1% |
| 357 | Rhabdomyoma | 5.1% |
| 358 | Chondromatosis | 5.1% |
| 359 | Adenocarcinoma, Clear Cell | 5.1% |
| 360 | Cholangiocarcinoma | 5.1% |
| 361 | Cervical Intraepithelial Neoplasia | 5.1% |
| 362 | Hemangioblastoma | 5.1% |
| 363 | Lymphoma, Extranodal NK-T-Cell | 5.1% |
| 364 | Lymphatic Metastasis | 5.1% |
| 365 | Neoplasms, Unknown Primary | 5.1% |
| 366 | Leukemic Infiltration | 5.1% |
| 367 | Breast Neoplasms, Male | 5.1% |
| 368 | Neoplasm Micrometastasis | 5.1% |
| 369 | Triple Negative Breast Neoplasms | 5.1% |
| 370 | Sickle Cell Trait | 5.1% |
| 371 | Fanconi Anemia | 5% |
| 372 | Adenomatous Polyposis Coli | 5% |
| 373 | Fibromatosis, Aggressive | 4.8% |
| 374 | Fibromatosis, Abdominal | 4.8% |
| 375 | Klatskin Tumor | 4.8% |
| 376 | Febrile Neutropenia | 4.8% |
| 377 | Leydig Cell Tumor | 4.8% |
| 378 | Atypical Hemolytic Uremic Syndrome | 4.8% |
| 379 | Prolactinoma | 4.8% |
| 380 | Growth Hormone-Secreting Pituitary Adenoma | 4.8% |
| 381 | Purpura, Hyperglobulinemic | 4.8% |
| 382 | Lambert-Eaton Myasthenic Syndrome | 4.7% |
| 383 | Testicular Neoplasms | 4.7% |
| 384 | Thrombocytopenic purpura | 4.6% |
| 385 | Peutz-Jeghers Syndrome | 4.5% |
| 386 | Lymphopenia | 4.3% |
| 387 | Mesoblastic Nephroma | 4.3% |
| 388 | Meningeal Neoplasms | 4.3% |
| 389 | Job Syndrome | 4.3% |
| 390 | Adrenocortical carcinoma | 4.2% |
| 391 | Adrenal Gland Neoplasms | 4.2% |
| 392 | Gastrointestinal Neoplasms | 4.2% |
| 393 | Genital Neoplasms, Male | 4.2% |
| 394 | Hypergammaglobulinemia | 4.2% |
| 395 | Liver neoplasms | 4.2% |
| 396 | Uveal Neoplasms | 4.2% |
| 397 | Urologic Neoplasms | 4.2% |
| 398 | Transfusion-Related Acute Lung Injury | 4.1% |
| 399 | Opsoclonus-Myoclonus Syndrome | 4.1% |
| 400 | granulosa cell tumor | 4.1% |
| 401 | Carcinoma, Ovarian Epithelial | 4.1% |
| 402 | Ecchymosis | 4.1% |
| 403 | Petechiae | 4.1% |
| 404 | Purpura | 4.1% |
| 405 | Sebaceous Gland Neoplasms | 4.1% |
| 406 | Spinal Neoplasms | 4.1% |
| 407 | Palatal Neoplasms | 4% |
| 408 | Hydrops Fetalis | 3.9% |
| 409 | Acute Chest Syndrome | 3.9% |
| 410 | Pulmonary Eosinophilia | 3.9% |
| 411 | Eosinophilic Pneumonia | 3.9% |
| 412 | Nose Neoplasms | 3.8% |
| 413 | Mastocytoma | 3.8% |
| 414 | Meningeal Carcinomatosis | 3.8% |
| 415 | Mastocytosis, Systemic | 3.8% |
| 416 | Anemia, Pernicious | 3.8% |
| 417 | Renal Cell Carcinoma | 3.7% |
| 418 | Papillary Renal Cell Carcinoma | 3.7% |
| 419 | Myelitis, Transverse | 3.7% |
| 420 | Niemann-Pick Disease, Type C | 3.6% |
| 421 | Carcinoma, Endometrioid | 3.6% |
| 422 | Denys-Drash Syndrome | 3.5% |
| 423 | Ear Neoplasms | 3.5% |
| 424 | Eyelid Neoplasms | 3.5% |
| 425 | Lung Neoplasms | 3.5% |
| 426 | Pleural Neoplasms | 3.5% |
| 427 | Mastocytosis | 3.4% |
| 428 | Sturge-Weber Syndrome | 3.4% |
| 429 | Eosinophilia-Myalgia Syndrome | 3.4% |
| 430 | Cell Transformation, Viral | 3.4% |
| 431 | Brain Neoplasms | 3.4% |
| 432 | Chronic granulomatous disease | 3.4% |
| 433 | Salivary Gland Neoplasms | 3.4% |
| 434 | Shwartzman Phenomenon | 3.4% |
| 435 | Spinal Cord Neoplasms | 3.4% |
| 436 | Tongue Neoplasms | 3.4% |
| 437 | Gastrointestinal Stromal Tumors | 3.4% |
| 438 | Primary amyloidosis | 3.4% |
| 439 | Nasopharyngeal carcinoma | 3.4% |
| 440 | Pituitary Adenoma | 3.4% |
| 441 | Pituitary Neoplasms | 3.4% |
| 442 | Scurvy | 3.4% |
| 443 | Uterine Neoplasms | 3.4% |
| 444 | Vaginal Neoplasms | 3.4% |
| 445 | Vulvar Neoplasms | 3.4% |
| 446 | Purpura Fulminans | 3.4% |
| 447 | Uterine Cancer | 3.4% |
| 448 | Fallopian Tube Neoplasms | 3.3% |
| 449 | neurofibroma | 3.3% |
| 450 | Waterhouse-Friderichsen Syndrome | 3.3% |
| 451 | Bronchial Neoplasms | 3.1% |
| 452 | Multiple Pulmonary Nodules | 3.1% |
| 453 | Supratentorial Neoplasms | 3% |
| 454 | Endometrial Neoplasms | 3% |
| 455 | Pharyngeal Neoplasms | 2.9% |
| 456 | Dupuytren Contracture | 2.9% |
| 457 | ovarian neoplasm | 2.9% |
| 458 | Urticaria Pigmentosa | 2.9% |
| 459 | Central Nervous System Cysts | 2.9% |
| 460 | Bile Duct Neoplasms | 2.8% |
| 461 | gallbladder neoplasm | 2.8% |
| 462 | Intestinal Neoplasms | 2.8% |
| 463 | Penile Neoplasms | 2.8% |
| 464 | Prostatic Neoplasms | 2.8% |
| 465 | Stomach Neoplasms | 2.8% |
| 466 | Brain Stem Neoplasms | 2.8% |
| 467 | POEMS Syndrome | 2.8% |
| 468 | Choroid Plexus Papilloma | 2.7% |
| 469 | Xeroderma Pigmentosum | 2.7% |
| 470 | Kernicterus | 2.6% |
| 471 | Hypopharyngeal Neoplasms | 2.5% |
| 472 | Pleural Effusion, Malignant | 2.5% |
| 473 | Hypopharyngeal Cancer | 2.5% |
| 474 | Laryngeal neoplasm | 2.5% |
| 475 | Parotid Neoplasms | 2.5% |
| 476 | Prostatic Neoplasms, Castration-Resistant | 2.5% |
| 477 | Nelson Syndrome | 2.5% |
| 478 | Bladder Neoplasm | 2.4% |
| 479 | Kidney Neoplasm | 2.4% |
| 480 | Ureteral Neoplasms | 2.4% |
| 481 | Urethral Neoplasms | 2.4% |
| 482 | Tonsillar Neoplasms | 2.4% |
| 483 | Cerebellar Neoplasms | 2.3% |
| 484 | Zollinger-Ellison syndrome | 2.2% |
| 485 | Cecal Neoplasms | 2.1% |
| 486 | Duodenal Neoplasms | 2.1% |
| 487 | Appendiceal Neoplasms | 2% |
| 488 | Colonic Neoplasms | 2% |
| 489 | Rectal Neoplasms | 2% |
| 490 | Nasopharyngeal Neoplasms | 1.9% |
| 491 | Pseudoxanthoma Elasticum | 1.9% |
| 492 | Colorectal Neoplasms | 1.9% |
| 493 | Paranasal Sinus Neoplasms | 1.7% |
| 494 | Anus Neoplasms | 1.7% |
| 495 | Sigmoid Neoplasms | 1.7% |
| 496 | Maxillary Sinus Neoplasms | 1.6% |